SCHEMBL22012648

SCHEMBL22012648

CC(C)(O)c1ncc(S(N)(=O)=NS)s1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.30
GCK P35557 1/20 0.30
GCKR Q14397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20680943 0.86 LOXL2 (0.31) LOXL2GCKGCKR
SCHEMBL21810624 0.84
SCHEMBL20692280 0.82 LOXL2 (0.32) LOXL2GCKGCKR
SCHEMBL22011765 0.82
SCHEMBL19475212 0.82 CA2 (0.36) LOXL2GCKGCKR
SCHEMBL20680910 0.80 LOXL2 (0.32) LOXL2GCKGCKR
SCHEMBL25067066 0.78 CA2 (0.35)
SCHEMBL22002763 0.78 CA2 (0.35)
SCHEMBL20681297 0.78 CA2 (0.35)
SCHEMBL22012021 0.77 FFAR2 (0.39) LOXL2GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed